General Dermatology
Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management

Navigating Pregnancy Safety and Systemic Treatments in Atopic Dermatitis : Episode 1

Unveiling Treatment Gaps: Expert Perspectives on the Undermanagement of Patients with Atopic Dermatitis and Childbearing Potential

June 12, 2024

Elizabeth Kiracofe, MD, FAAD
Jenny Murase, MD, FAAD

Opinion

Video

Dr. Elizabeth Kiracofe, MD, FAAD, and Dr. Jenny Murase, MD, introduce a discussion on the undertreatment of patients with atopic dermatitis, particularly focusing on pregnant individuals and those of childbearing age.

Now Viewing

EP: 1.Unveiling Treatment Gaps: Expert Perspectives on the Undermanagement of Patients with Atopic Dermatitis and Childbearing Potential

EP: 2.Fostering Communication: Promoting Dialogue on Atopic Dermatitis Treatment Concerns in Patients of Childbearing Potential

EP: 3.Exploring Changes in Atopic Dermatitis Severity Across the Pregnancy Journey

EP: 4.Navigating Treatment Choices: Balancing Treatment Options for Childbearing-Age Patients

EP: 5.Insights on Transcription Binding in Atopic Dermatitis

EP: 6.Informed Decisions: Dialogue with Treatment-Naïve Pregnant Patients Regarding Systemic Atopic Dermatitis Treatment Options

Video content above is prompted by the following question(s):

Please comment on the issue of undertreatment and underdosing in pregnant populations, even when data supports their potential efficacy and safety.
How might this bias hinder optimizing care and the willingness to use potentially higher-risk but more efficacious systemic therapies?